Marché européen des services de laboratoire clinique – Tendances et prévisions du secteur jusqu’en 2030

Analyse et taille du marché des services de laboratoire clinique en Europe

Le marché devrait gagner du terrain. L'application croissante des tests à haut débit et les progrès des méthodes de diagnostic clinique agissent comme des moteurs de la croissance du marché.

Les laboratoires cliniques fournissent des produits de test aux organismes de santé publics et privés, notamment les centres de santé, les cliniques, les centres médicaux et les maisons de retraite. Les domaines de recherche en laboratoire protégés par l'accréditation comprennent la chimie médicinale, la microbiologie clinique , l'hématologie, l'anatomie, la physique clinique, la psychologie, la médecine nucléaire et la neurophysiologie clinique.

Data Bridge Market Research analyse que le marché européen des services de laboratoire clinique devrait atteindre la valeur de 142 830,94 millions USD d'ici 2030, à un TCAC de 6,6 % au cours de la période de prévision.              

Définition du marché

Les laboratoires cliniques sont un élément important du secteur de la santé. La plupart des tests de diagnostic , de l'analyse sanguine à l'analyse génétique, sont effectués dans ces laboratoires cliniques pour détecter différentes maladies. Les laboratoires cliniques offrent des données et des ressources qui optimisent la distribution requise dans le système de santé, comme les diagnostics et les résultats des tests. Cela permet de conserver et de fournir des résultats de test fiables et corrects qui permettent aux médecins de prendre des décisions cliniques et diagnostiques appropriées à différents niveaux des services de soins de santé. Cela permet aux cliniciens d'adapter, de commencer et d'arrêter le traitement, ce qui serait entravé en l'absence d'installations de laboratoire médical. Les services de laboratoire clinique comprennent la découverte de médicaments, le développement de médicaments, la chimie bioanalytique et de laboratoire, les tests de toxicologie, la thérapie cellulaire et génique et les services liés aux essais précliniques et cliniques. Les laboratoires indépendants et de référence, les laboratoires hospitaliers, les laboratoires infirmiers et les laboratoires de cabinet médical sont quelques-uns des principaux fournisseurs de services de laboratoire clinique.

Dynamique du marché

Cette section traite de la compréhension des moteurs, des avantages, des opportunités, des contraintes et des défis du marché. Tout cela est discuté en détail ci-dessous :

Conducteur

• Augmentation des cas de maladies infectieuses

Ces derniers temps, l'incidence croissante des maladies infectieuses , telles que les épidémies virales et les agents pathogènes résistants aux antibiotiques, a augmenté la demande de tests de diagnostic et de services de laboratoire clinique. Les maladies infectieuses causées par des organismes tels que les virus, les parasites, les champignons et les bactéries sont transmises directement ou indirectement d'une personne à une autre. Les laboratoires cliniques investissent massivement dans des technologies de diagnostic avancées, notamment les diagnostics moléculaires et les tests sérologiques, pour identifier et gérer efficacement ces maladies. L'augmentation des maladies infectieuses a un impact croissant sur la demande de laboratoires cliniques pour le diagnostic en laboratoire des maladies infectieuses des patients. Le laboratoire clinique fournit différents types de services pour le diagnostic et le traitement des patients atteints de maladies infectieuses, notamment la numération sanguine, les tests d'immunologie et d'allergie et l'analyse d'urine, entre autres.

Opportunités

• Popularité croissante des plateformes de pathologie numérique

Digital pathology platforms are computer workstations used to view digital whole slide images acquired from glass microscope high-resolution slide scanning. Digital pathology platforms use algorithms for analysis and diagnostic reporting to ensure reproducibility, greater accuracy, and standardization of studies. Applications of digital pathology platforms are increasing in various clinical laboratories to implement full-scale operations in the laboratories successfully. In addition, the adoption of digital pathology platforms has increased as whole slide imaging has shown various improvements in scanner capacities, scan times, image resolution, image management software, laboratory information systems integration, and simple image viewing and evaluation.

Digital pathology platforms have displayed their utility in team communication, case management, workflow acceleration and facilitation in image analytics, slide imaging, tumor boards, and remote consultations, which is creating a more collaborative, efficient, and rewarding environment for researchers and clinicians, which in increasing adoption of digital pathology platforms around the world.

The adoption of digital pathology platforms is increasing in developed and developing countries due to increasing functional ability in various departments in the clinical laboratory, including training, teaching, team communication, research activities, and primary diagnostic reporting. Digital pathology platforms have shown their efficacy in clinical laboratories with many benefits in clinical laboratory operations.

• Growth in Awareness Among Population for Preventive Health Check-Ups

Preventive health check-ups are preventive actions performed for the initial detection of disease and to safeguard against likely exposure to any disease in the future. The check-up is comprised of the identification of disease and examinations of risk factors to limit loss at an early stage. Preventive health check-ups are performed with the help of various lab tests, including blood chemistry, hemoglobin, urinalysis, screening for prostate cancer, screening for ovarian cancer, ECG, lipid panel, and others.

Preventive health check-ups are increasing worldwide as various studies and research have proven their effectiveness in disease prevention and economics. Furthermore, the demand for preventive health check-ups has increased as preventive health check-ups are insured by health insurance companies in various counties, and the current COVID-19 situation has added up as a necessity for the safety of individuals. When a communicable disease outbreak begins, the ideal response is for public health officials to begin testing for it early. That leads to quick identification of cases, quick treatment for those people, and immediate isolation to prevent spread. Early testing also helps to identify anyone who came into contact with infected people so they too can be quickly treated.

Restraints/Challenges 

• Lack of Skilled and Certified Professionals

The requirement for skilled and certified professionals is a big restraint for clinical laboratories. Clinical laboratory services have increased due to the high growth in the number of people aged 65 or older who need a routine diagnostic test for their health, but the number of skilled professionals present in the laboratory center is expected to restrain the market growth. The method and laboratory procedure have advantages, but there are certain gaps in standardization, equalization, and knowledge. Technicians are facing technical training gaps related to problems in adopting advanced methods safely to perform procedures efficiently. There is a need for highly skilled professionals in the clinical laboratory for method development, validation, operation, and troubleshooting activities.

• Inaccurate Test Outcomes Undermining Precision and Reliability

Inaccuracies in diagnostic test outcomes have negative consequences for patient safety, potentially leading to misdiagnoses or delayed diagnoses that harm patients' health. Many Inaccurate results and diagnostic test errors are linked to laboratory practices. Laboratory practice could be divided into three segments which are pre-analytical, analytical, and post-analytical.

Analytical Errors: During the establishment and verification of test methods as per the performance specifications to test precision, accuracy, specificity, sensitivity, and linearity are the areas where errors are high in clinical laboratory testing.

Pre-Analytical Errors: The pre-analytical error phase is the process where the maximum laboratory errors occur. Pre-analytical errors can arise during patient assessment, patient identification, request completion, test order entry, specimen transport, specimen collection, and specimen receipt in the laboratory.

Post-Analytical Errors: The post-analytical phase is the phase of diagnostic and therapeutic decisions. Post-analytical errors can arise due to inappropriate use of laboratory test outcomes, the transmission of correct outcomes, and critical outcomes reporting are areas of potential error in the post-analytical phase of the total laboratory testing process.

Recent Developments

• In August 2023, Abbott received FDA clearance for its Alinity h-series hematology system, expanding its diagnostic Service lineup for complete blood counts (CBC) testing. This system is crucial in routine checkups, aiding in the screening of various disorders such as infections, anemia, immune system diseases, and blood cancers. The Alinity h-series comprises Alinity hq, an automated hematology analyzer, and Alinity hs, an integrated slide maker and stainer. Notably, Alinity HQ employs MAPSSTM technology for advanced cell identification using light scattering.
• In November 2022, Microba Life Sciences announced a strategic partnership with Sonic Healthcare Limited, a global leader in medical diagnostics. Sonic is set to acquire a 19.99% stake in Microba, with an option for an additional 5% pending shareholder approval.

Market Scope

Europe clinical laboratory services market is categorized into four notable segments on the basis of specialty, technology, provider, and application. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Specialty

• Clinical Chemistry Testing
• Hematology Testing
• Microbiology Testing
• Immunology Testing
• Drugs of Abuse Testing
• Cytology Testing
• Genetic Testing
• Anatomic Pathology Services
• Other Estoric Testing    

On the basis of specialty, the market is segmented into clinical chemistry testing, hematology testing, microbiology testing, immunology testing, drugs of abuse testing, cytology testing, genetic testing, anatomic pathology services and other esoteric testing. 

Technology

• Enzyme-Linked Immunosorbent Assay
• Real-Time PCR
• Chemiluminescence Immunoassay
• Mass Spectrometry
• Flow Cytometry
• DNA Sequencing
• Other Technologies 

On the basis of technology, the market is segmented into enzyme-linked immunosorbent assay, real-time PCR, chemiluminescence immunoassay, mass spectrometry, flow cytometry, DNA sequencing and other technologies.    

Provider

• Hospital-Based Laboratories
• Independent & Reference Laboratories
• Nursing and Physician Office-Based Laboratories
• Clinic Based Laboratories

On the basis of provider, the market is segmented into hospital-based laboratories, independent & reference laboratories, nursing and physician office-based laboratories, and clinic-based laboratories. 

Application

• Bioanalytical & Lab Chemistry Services
• Drug Discovery and Development Related Services
• Toxicology Testing Services
• Cell & Gene Therapy Related Services
• Preclinical & Clinical Trial Related Services
• Other Clinical Laboratory Services 

On the basis of application, the market is segmented into drug discovery and development related services, bioanalytical & lab chemistry services, toxicology testing services, cell & gene therapy related services, preclinical & clinical trial related services, and other clinical laboratory services.

Regional Analysis/Insights

The Europe clinical laboratory services market is categorized into four notable segments on the basis of specialty, technology, provider, and application.

The countries covered in the Europe clinical laboratory services market report are Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland and Rest Of Europe.                   

Germany is expected to dominate the market due to its advanced healthcare infrastructure and extensive network of high-quality clinical laboratories.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements dans la réglementation du marché qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces du porteur, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques régionales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et des routes commerciales sont pris en compte lors de l'analyse prévisionnelle des données nationales .   

Analyse du paysage concurrentiel et des parts de marché

Le paysage concurrentiel du marché européen des services de laboratoire clinique fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence régionale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises sur le marché européen des services de laboratoire clinique.

Certains des principaux acteurs opérant sur le marché européen des services de laboratoire clinique sont Mayo Foundation for Medical Education and Research, Quest Diagnostics Incorporated, Eurofins Scientific, UNILABS, SYNLAB International GmbH, HU Groups Holdings, Inc., Sonic Healthcare Limited, ACM Global Laboratories, Amedes Medical Services GmbH, Abbott, Charles River Laboratories, Cerba Healthcare, Q2 Solutions (une filiale d'IQVIA Inc) et entre autres.

SKU-50621